This seminar illustrates content of contracts for outsourcing and demonstrates assembly
of new production sited for diagnostic / therapeutic agent manufacturing under
consideration of contract manufacturing.
Outsourcing of biological production is attractive to small to medium sized companies
as well as to global players. Small companies require expertises from specialised
service providers (e.g. in GMP manufacturing) to reduce time to market. Big companies
need relief in own occupied production facilities and switch to appropriate service
providers delivering extended production capacity. Therefore a complete new market
has emerged providing all stages of biotech manufacturing and bioanalysis.
Prospective project managers dealing with contract manufacturing (as OEM or CM) are
in charge of reducing time to market drastically by choosing appropriate contract
manufacturer. Due to high investments into R&D and production time to market
represents most important factor in biological productions.
This seminar illustrates content of contracts for outsourcing and demonstrates assembly
of new production sited for diagnostic / therapeutic agent manufacturing under
consideration of contract manufacturing.
